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1
Introduction
In the last two decades blood oxygenation level dependent (BOLD) functional
magnetic resonance imaging (fMRI) has become a widely used tool in neuro-
scientific research. After the relation of neuronal activity and BOLD signal
was discovered, fMRI was used to detect neuronal responses to various tasks
compared to control periods during which the brain was considered inactive
(Biswal, Zerrin Yetkin, Haughton, & Hyde, 1995). However, some regions of
the brain were found to be active especially in this resting condition (Raichle
et al., 2001). The discovery of the so called default mode network (DMN)
evoked increasing interest in resting state investigations and resting state fMRI
(rs-fMRI) has evolved into an active and fruitful field of research. Many studies
have investigated alterations in resting state brain function induced by various
abnormal conditions including psychiatric disorders and drug induced states.
Rs-fMRI also provides the possibility to define networks on the level of brain
regions, which can yield valuable information about functional processes in the
brain.
In recent years, neuroscientists, especially in functional imaging, are increas-
ingly regarding the brain as a complex network (Bassett & Sporns, 2017; Sporns,
2011; Bullmore & Sporns, 2009). Therefore, network scientific methods have
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gained great popularity in neuroscience and are widely used in the field. Due
to its high degree of abstractness the network representation allows for direct
comparison between different studies and even different species.
Since preclinical MR scanners and sequences provide sufficient spatio-
temporal resolution for functional imaging, there are more and more preclinical
studies providing network results directly comparable to clinical studies or di-
agnostic data (Lu et al., 2012). Comparability of results across species is vital
for translational research and the validation of animal models. Therefore, net-
work methods appear to be especially useful in preclinical research. Direct
comparison between human and animal studies can provide valuable results for
validation of animal models. Nevertheless, studies directly comparing network
results across species are rare.
In clinical research, psychiatric disorders are considered to be related to or
even caused by disrupted brain networks (van den Heuvel & Hulshoff Pol, 2010;
Braun, Muldoon, & Bassett, 2015), reflecting the connectomic view of the brain.
Relating network phenotypes to clinical outcome could facilitate the definition
of biomarkers quantifying psychiatric disorders as well as therapeutic success.
Major depressive disorder (MDD), one of the most prevalent psychiatric dis-
orders, has been shown to affect functional connectivity and resting state net-
works in clinical studies as well as animal models (Mulders, van Eijndhoven,
Schene, Beckmann, & Tendolkar, 2015; Q. Gong & He, 2015; Gass et al., 2016).
There is considerable variation between studies due to the heterogeneity of the
disease and differences in selection of patients (e.g. treatment resistance, medi-
cation). Nevertheless, there are results, including improved network integration
and impaired reward processing, which keep recurring across studies (Q. Gong
& He, 2015; L. Gong et al., 2017). Since brain networks are found to be al-
tered in depression, network effects of antidepressant treatment are naturally
an interesting target of investigation, especially in evaluating the effects and
mechanisms of action of possible new antidepressants like ketamine.
Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, is a well
established general anaesthetic, especially for use in emergency situations. Ke-
tamine anaesthesia improves the outcome of electroconvulsive therapy in treat-
ment resistant depression (Kranaster, Kammerer-Ciernioch, Hoyer, & Sartorius,
2011). Furthermore it was found to act antidepressantly at subanesthetic doses
(Berman et al., 2000). Unlike classic antidepressants, like selective serotonine
reuptake inhibitors (SSRI), ketamine was found to act very quickly. While SSRI
usually need weeks to take full effect, ketamine significantly improves depres-
sive symptoms within hours after a single injection (Diazgranados, Ibrahim,
Brutsche, & et al., 2010; Zarate et al., 2006). Furthermore the antidepressant
effect of ketamine is very reliable. Improvement of depression scores was found
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across studies in unipolar and bipolar depression (McGirr et al., 2015) and even
treatment-resistant patients responded to ketamine (Diazgranados et al., 2010).
However the antidepressant effect comes at the price of dissociative side effects
preventing a wider clinical usage of ketamine (Vollenweider & Kometer, 2010).
There is evidence suggesting that antidepressant and dissociative effects are
based on the same neurochemical mechanisms (Niciu et al., 2018; Vollenwei-
der & Kometer, 2010). Regarding functional connectivity ketamine strengthens
connections within the prefrontal corex (PFC) as well as hippocampal-prefrontal
coupling (Gass et al., 2014; Grimm et al., 2015). Whether these network effects
reflect the antidepressant or the dissociative actions of ketamine is subject to
ongoing investigation.
Since the antidepressant effect of ketamine has been discovered, there is in-
creasing interest in NMDA antagonists in the research of antidepressant drugs.
Alternative drugs could be found among compounds sharing ketamine’s rapid
antidepressant action without exhibiting strong side effects. There are results
suggesting that ketamine’s antidepressant action originates from its effect on the
NR2B subtype of NMDA receptors (Miller et al., 2014). Therefore, antagonists
exclusively targeting this subgroup are promising candidates for new antidepres-
sant drugs. One compound belonging to this group is traxoprodil (CP101,606),
which has shown antidepressant efficacy in clinical studies (Preskorn et al.,
2008). Another candidate drug possibly showing this profile is lanicemine
(AZD7665), an NMDA channel blocker with lower trapping than ketamine.
In clinical studies it showed short lived antidepressant efficacy (Sanacora et al.,
2014; Zarate et al., 2013).
Understanding the mechanism underlying both, the antidepressant and dis-
sociative effects, is important for the development of glutamatergic antidepres-
sants. Investigation and comparison of network effects induced by different
NMDA receptor antagonists promises further insight into these mechanisms.
Effects on the connectivity within the PFC as well as hippocampal-prefrontal
coupling are especially interesting as differences between drugs might help un-
derstanding how network alterations induced by NMDA antagonists are related
to antidepressant or dissociative effects.
1.1 Aims
One aim of this work is the translation of network methods, which are mostly
applied in human studies, to preclinical research. Direct comparison of network
effects across species is important for validation of the translational potential
these methods have for pharmacological research as well as basic neuroscience.
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In order to examine inter-species translatability of network methods, data ob-
tained in resting state fMRI experiments studying the effects of ketamine on
human and rat brains are analysed and results are compared across species
(chapter 3). The hypothesis tested here is that ketamine induces similar net-
work effects in both species.
Understanding the processes underlying the effects of NMDA antagonists is
vital for the development of this new class of potential antidepressants. To that
end, the acute actions of traxoprodil and lanicemine on networks in the rat
brain are investigated in an exploratory study (chapter 4). Both drugs’ effects
on resting state connectivity and graph theoretical properties of brain networks
are examined and compared to the effects of ketamine found in previous studies,
which include increased connectivity in the hippocampal-prefrontal network
(Gass et al., 2014) as well as reduced network integration and improved reward
processing (Gass et al., 2018). Since clinical studies found antidepressant effects
of ketamine and traxoprodil, network effects are hypothesised to be congruent as
well. For lanicemine similar but less pronounced effects compared to ketamine
are expected due to the similar mechanism of action.
4
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Network methods in neuroscience
2.1 Network definition
The basic idea of network science is to represent a system by a group of nodes
connected by edges carrying certain weights representing the strength of con-
nection. Legend has it that the birth of network science was Euler’s consid-
eration, whether there is a closed path through Königsberg which uses each
of the bridges exatly once (Euler, 1736). Since then a branch of mathematics
called graph theory has evolved, which provides a formalism for this kind of
topolagical problems (Diestel, 2017).
In brain networks derived from fMRI measurements nodes are usually
anatomically defined brain regions, provided by an atlas, e.g. the ones by
Schwarz et al. (2006) for rats, or by J. Power et al. (2011) for humans. Edge
weights are obtained by pairwise correlation of the mean regional BOLD time-
courses (van den Heuvel & Hulshoff Pol, 2010). Figure 1 shows the network
definition procedure schematically. As correlation is undirected (cor(A,B) =
cor(B,A)), a network of N regions contains 12N(N − 1) edges.
While this is the most common definition, it is by far not the only one. For
instance, some studies use widespread activation patterns obtained by indepen-
dent component analysis (ICA) instead of anatomically defined regions as nodes
(Jafri, Pearlson, Stevens, & Calhoun, 2008), some apply alternative measures of
5
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Figure 1: Definition of networks from rs-fMRI data. A: Brain parcellation by anatom-
ical atlas; B: Pairwise correlation of regional timecourses; C: adjecency matrix with
1
2N(N − 1) correlation coefficients. D: Sparse network for further analysis.
connectedness between regional signals like wavelet coherence (Grinsted, Moore,
& Jevrejeva, 2004; Chai et al., 2017) or Granger’s causality (Bressler & Seth,
2011; Liao et al., 2011).
Formally a graph is defined by a set of nodes and a set of edges connecting
them.
G = (V, U) ,
where V is set of N nodes and a U a set of M ≤ N(N − 1) edges.
A useful representation is an N × N -matrix containing the connections of
the edges. The adjacency matrix A gives the connection status of each pair of
nodes:
aij =
1, if nodes i and j are connected0, otherwise
If differently strong connections are allowed for, the weighted connectivity
matrix W contains the weights wij of connections.
While consideration of the weights wij is essential in the analysis of connec-
tivity, network topology can also be examined in the binary adjacency matrix
A. Using weighted connections can unveil subtle topological changes, which
are not detected by the binarized analysis, but possible interference of general
connectivity changes and topological effects has to be accounted for.
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2.2 Network analysis
Having defined a brain network, regional connectivity can be analysed, with-
out calculating any higher level network metrics. Straight forward statistical
methods like conventional parametric tests on the single network edges often
yield interesting results in group comparisons (Gass et al., 2014). There are
also more sophisticated methods available to analyse interregional connectiv-
ity. One widely used method is network based statistics introduced by Zalesky,
Fornito, and Bullmore (2010). The basic idea of this approach is to compare
connectivity at the level of clusters of nodes instead of analysing connections
one by one. It is a translation of the known cluster based methods in statis-
tical parametric mapping from the voxel to the network level. A conventional
parametric test for the connections is performed and the network is sparsed by
discarding all edges not exceeding an appropriate threshold value of the test
statistic. In the thresholded network, connected subgroups are detected. Sub-
sequently, group statistics are run with regard to these clusters, which leads to
more robust results than classic statistics.
2.2.1 Network metrics
Apart from the analysis of connectivity itself, there is a large variety of net-
work metrics which can yield information about network topology, which is
not captured by the analysis of connectivity (Rubinov & Sporns, 2010; Sporns,
2011).
Nearly all approaches for network definition result in fully connected net-
works, i.e. every possible pair of nodes is connected. In order to get a meaning-
ful and interpretable network it is necessary to sparsen the network. However,
there is no consensus on which density to choose. In order to avoid arbitrarily
choosing a single density, it is common to analyse networks over a range of den-
sities and calculate the average values of network metrics, the area under the
curve (AUC). Furthermore, there is no consensus on how to handle negatively
weighted edges, as there is no conclusive interpretation and most network met-
rics can not be calculated for networks containing positive and negative weights.
Therefore, the network analyses discussed in the following are restricted to net-
works consisting of positively weighted edges.
The selection of network metrics introduced here shall be mainly focused on
those which are used for data analysis in chapters 3 and 4. Some network
metrics are illustrated on an example network in Figure 2.
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Figure 2: Illustration of some network metrics. A: Measures of integration, the edges
shown in green form the shortest path between nodes A and B; node C (marked in
red) is an example of a highly central node. B: Measures of segregation, clustering of
node A is calculated based on the edges marked in yellow, which connect neighbours of
A; the left and right halves of the network (dashed lines) are well separable modules.
Basic metrics
The degree k of a node is the number of edges connecting it to others, and its
strength s is the sum of weights of these connections:
ki =
∑
j∈V
aij ; si =
∑
j∈V
wij ,
where aij are the entries of the adjacency matrix A and wij the connection
weights.
The distance between nodes i and j is given by the length of the shortest
path connecting them (Watts & Strogatz, 1998; Rubinov & Sporns, 2010):
dij =
∑
auv∈gi↔j
1
wuv
,
where gi↔j is the shortest path between i and j, wuv the connection weights.
8
2.2 Network analysis
Metrics of integration
Integration is the ability of a network to transfer information between any two
nodes. Metrics of integration are based on the lengths of paths between nodes.
The characteristic path length of a network is the average shortest path length
over all pairs of nodes, which are connected:
L = 1
N(N − 1)
∑
i,j∈V,
i 6=j,aij 6=0
dij ,
where N is the total number of nodes and dij the distance between nodes i
and j.
An alternative metric of integration, the network’s efficiency, is given by the
average inverse shortest path length (Latora & Marchiori, 2001, 2003)
E = 1
N(N − 1)
∑
i,j∈V,
i 6=j
1
dij
,
where N is the total number of nodes and dij the distance between nodes i
and j.
Unlike the characteristic path length it can be meaningfully calculated on
unconnected networks. Paths between non-connected nodes i, j have infinite
length dij → ∞, and do not contribute to the efficiency E, while they have to
be explicitly excluded from calculation of the characteristic path length to avoid
infinite values of L (note the additional restriction aij 6= 0 in the calculation)
Metrics of segregation
Segregation describes the ability of a network for localized processing. Highly
segregated networks consist of highly connected, but separated subgroups and
are therefore capable of processing information in parts of the network without
disturbing others. This ability is also advantageous for many types of networks
(Rubinov & Sporns, 2010; Sporns, 2011). Segregation can be quantified by the
average clustering coefficient. A node’s clustering coefficient is defined as the
percentage of possible connections existing between its neighbours scaled by the
edge weights:
Ci =
1
ki(ki − 1)
∑
j,h∈N
(wijwihwjh)
1
3 ,
where ki is the degree of node i, wij the weight of the connection between
nodes i and j.
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The global clustering coefficient of a network is the average of the clustering
coefficients of all its nodes.
C = 1
N
∑
i∈V
Ci
While the clustering coefficient is restricted to direct connections between
the neighbours of i, the local efficiency also takes longer paths into account as
long as they only contain neighbours of i. It is defined as the efficiency of the
subnetwork formed by the neighbours.
Eloc,i =
1
ki(ki − 1)
∑
j,h∈N
(wijwih(djh(i))−1)
1
3 ,
where djh(i) is the distance between j and h only containing neighbours of i.
The local efficiency as a summary measure quantifying the segregation of the
whole network is again given by the average of over all nodes:
Eloc =
1
N
∑
i∈V
Eloc,i
Another feature of segregation is the modular structure of a network. Mod-
ules are non-overlapping groups of nodes which have relatively high intrinsic
connectivity, while being weakly connected to each other. The modularity Q, a
measure of partition quality, is given by the average difference between within
module connectivity of a given partition and within module connectivity ex-
pected by chance.
Q = 1
ν
∑
ij
(wij − eij)δMiMj ,
where ν = ∑ij wij is the total weight of all edges, eij = sisjν the within-module
connectivity expected by chance, and δMiMj = 1 if nodes i and j belong to the
same module and δMiMj = 0 otherwise.
There are several algorithms available to find the optimal partitioning in nu-
merical optimization processes maximizing Q (Newman, 2004; Blondel, Guil-
laume, Lambiotte, & Lefebvre, 2008).
Small-world networks
Networks having high integration as well as high segregation are called small-
world networks (referring to the known phenomenon of the world being smaller
than we think)(Milgram, 1967; Watts & Strogatz, 1998). This structure can
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be found in many real life networks like social communities, public transport
or telecommunication (Latora & Marchiori, 2002; Guimerà, Mossa, Turtschi, &
Amaral, 2005).
Brain networks are also supposed to show small-world structure (Bassett &
Bullmore, 2006). The extent to which they do can be quantified by the small
world index σ, which is given by the global clustering coefficient C divided by
the characteristic path length L of the network:
σ = C
L
When compared to the small-worldness σrandom of a randomly structured net-
work of the same size and density, the value of σ gives the extent of small-world
topology. Small world networks are better segregated than random networks,
while remaining similarly integrated, thus σsmall−world
σrand
> 1.
Centrality
Regarding the role of individual nodes in a network, their centrality is of in-
terest. Metrics of centrality tell us how important a node is for a network’s
functionality. The simplest metric of centrality is the degree (see above).
A more sophisticated measure is the betweenness centrality index bi, i.e. the
fraction of shortest paths passing through a node:
bi =
1
(N − 1)(N − 2)
∑
j,h∈V,
i 6=j,j 6=h,h6=i
ρjh(i)
ρjh
,
where ρjh is the number of shortest paths between j and h, and ρjh(i) the
number of shortest paths between j and h passing through i.
Network Motifs
Network motifs are small subnetworks, usually consisting of three or four nodes,
which occour in a network (Sporns & Kotter, 2004; Onnela, Saramäki, Kertész,
& Kaski, 2005). The frequency of occurrence of different motifs around a spe-
cific node, its motif fingerprint, yields information about the nodes role in the
network, e.g. closed circuit or cyclic motifs are reflecting high clustering and
local processing whereas chain shaped motifs are associated with long-range
connections and general integration. Depending on the topology of motifs oc-
curring in the network in total, topological properties can be determined. A set
of motifs suitable for the analysis of undirected networks is shown in Figure 3.
11
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Figure 3: Set of 3 and 4 node motifs suitable for the analysis of undirected networks.
A-D and H are cyclic motifs associated with network segregation, E-G are acyclic,
integrative motifs
The intensity Ih of a motif h is given by:
Ih =
∑
u∈Uh
 ∏
(i,j)∈Lhu
wij
 1lh ,
where Uh is the set of all occurrences of motif h, Lhu is the set of links in the
uth occurrence of h and lh the number of edges in motif h.
Normalizing to randomized networks
In order to achieve comparability of network metrics between individual net-
works, it is necessary to normalize them by according metrics calculated on
randomized networks. These randomized networks or null models are obtainied
by randomly redistributing the edges of the original network. Thereby the
general structure of the network is maintained by preserving the distributions
of degree and strength (Rubinov & Sporns, 2011). Since the randomized net-
works can vary significantly between runs, the outcome of many runs of the
randomization process has to be averaged.
12
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2.2.2 Image preprocessing
Before calculating networks, the raw fMRI recordings have to undergo some
preprocessing. While there is no general consensus on which methods should
be included in the preprocessing procedure, some of them can have considerable
impact on the network outcome (Gargouri et al., 2018; Braun et al., 2012).
Especially the filtering of nuisance variables, mostly related to subject mo-
tion, breathing, and heartbeat from the fMRI data is considered important. The
standard procedure of filtering motion related signal changes out of the fMRI
timeseries is a linear regression of motion parameters directly obtained from the
data during image realignment. But some researchers claim that this does not
lead to sufficient removal of motion related signal and suggest more sophisti-
cated methods. These include simply removing datapoints (“scrubbing”) based
on motion detection methods like framewise displacement (FD) or DVARS
(J. D. Power, Barnes, Snyder, Schlaggar, & Petersen, 2012; J. D. Power et
al., 2014) or regressing additional data like externally recorded breathing and
cardiac signals or more elaborate data driven methods like wavelet despiking
(Patel et al., 2014) or ICA based methods. In the latter, the fMRI signal is de-
composed into a number of components using independent component analysis
(ICA) (Hyvärinen, Karhunen, & Oja, 2001). Then, components representing
noise are discarded before reconstructing the data. Selecting those components
which are considered noise by visual inspection is time consuming and prone
to all kinds of bias the researcher classifying the components might be prone
to. Therefore, automated component selection was developed by Pruim et al.
(2015).
2.3 Studies
There have been numerous studies in the recent years which investigated net-
work effects of many kinds of influencing factors including medication, psychi-
atric disorders on both interregional connectivity as well as the network metrics
described above.
The network methods which were implemented in the course of this work
have allready been used in several studies by the research group Translational
Imaging at the Central Institute of Mental Health. In a rat model of treatment
resistant depression we found increased centrality along with reduced local ef-
ficiency for hubs of the DMN compared to stress resilient rats (Gass et al.,
13
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2016). Optogenetic inhibition of the lateral habenula caused a reduction of
DMN connectivity in the same animal model (Clemm von Hohenberg et al.,
2018).
Examining the network effects of NR2B specific NMDA antagonists we found
network effects opposite to those found in depressive patients (Gass et al., 2018).
Like ketamine, traxoprodil induced decreased network integration and local
alterations in several regions related to reward processing.
In socially isolated rats, a model of early life stress, we found reduced modu-
larity of resting state brain networks as well as a shift of centrality from frontal
to posterior regions (Reinwald et al., 2018).
In a study investigating effects of pain chronification in a mouse model of neu-
ropathic pain we found a reduction in small-world structure as acute response
one week after pain induction by spared nerve injury. Interestingly, network
topology was reversed during pain chronification over the following 11 weeks
(Bilbao et al., 2018).
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Study: Species-conserved
reconfigurations of brain networks
induced by Ketamine
This chapter was published in Translational Psychiatry in 2016 (Becker et al.,
2016).
3.1 Abstract
Species-conserved (intermediate) phenotypes that can be quantified and com-
pared across species offer important advantages for translational research and
drug discovery. Here, we investigate the utility of network science methods to
assess the pharmacological alterations of the large-scale architecture of brain
networks in rats and humans. In a double-blind, placebo-controlled, cross-over
study in humans and a placebo-controlled two-group study in rats, we demon-
strate that the application of ketamine leads to a topological reconfiguration
of large-scale brain networks towards less-integrated and more-segregated infor-
mation processing in both the species. As these alterations are opposed to those
commonly observed in patients suffering from depression, they might indicate
systems-level correlates of the antidepressant effect of ketamine.
15
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3.2 Introduction
Ketamine, a potent N-methyl-D-aspartate (NMDA)-receptor antagonist, has
spurred considerable interest in preclinical as well as clinical applications. Its
effects range from anesthesia after acute application of high doses to psy-
chomimetic symptoms, derealization and cognitive disruption (Anticevic et al.,
2015; Höflich et al., 2015) as well as relatively rapid but long-lasting antide-
pressant action after acute administration of lower doses (Autry et al., 2011;
Berman et al., 2000; Zarate et al., 2006). Furthermore, ketamine is widely stud-
ied in both human and laboratory animals as a translational pharmacological
model of glutamatergic (dys-)function in schizophrenia (Anticevic et al., 2015;
Gass et al., 2014; Inta, Sartorius, & Gass, 2015; Stone, 2009).
Several studies have probed the underlying neurobiological substrates of these
actions in humans (Grimm et al., 2015; Höflich et al., 2015; Joules et al., 2015;
Scheidegger et al., 2012; Scheidegger et al., 2016) and animals (Gass et al.,
2014; Grimm et al., 2015; Lv et al., 2015) using neuroimaging approaches, but
have largely focused on specific brain regions and their interactions. The first
explicit demonstration of the translational potential of these methods showed
altered prefrontal-hippocampal coupling after ketamine application in rats and
humans, using a fMRI resting-state functional connectivity approach (Grimm
et al., 2015).
However, given the ubiquity of NMDA receptors throughout the brain (Sana-
cora, Zarate, Krystal, & Manji, 2008), it is likely that ketamine modulates
large-scale neural networks on the system-level, beyond alterations in single
brain regions or specific circuits.
Developing translational biomarkers that are able to capture these global re-
configurations in a biologically meaningful way is a priority for drug research
in psychiatry (Sanacora et al., 2008; Smucny, Wylie, & Tregellas, 2014). The
application of network analysis in combination with task-independent brain
imaging has been suggested as a key analytical tool, as network organization
is closely linked to brain function (Sporns, 2011, 2013). Providing a formal
representation of brain function, network analysis allows these fundamental
neurobiological organizational principles to be quantified across species. Re-
cent studies have successfully established graph theoretical metrics as reliable
(Braun et al., 2012; Cao et al., 2014; Schwarz, Gass, Sartorius, Risterucci, et al.,
2013; Schwarz & McGonigle, 2011) and sensitive biomarkers of normal (Bassett,
Nelson, Mueller, Camchong, & Lim, 2012; Schwarz, Gozzi, & Bifone, 2009) and
psychopathology-associated network function (Bassett et al., 2008; Bassett et
al., 2012), both in humans and animals. Previous work also shows key network
metrics to be conserved across species (Kaiser & Varier, 2011) and comparable
16
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between biological neuronal networks and computers (Bassett et al., 2010), fur-
ther suggesting that this approach may be useful for translational research and
biotechnological development.
Our aim was to investigate how acute ketamine challenge modulates the topo-
logical characteristics of the brain-wide functional connectome in both rats and
humans, and to assess the consistency of the large-scale network changes across
species.
3.3 Methods
3.3.1 Subjects and ketamine application
Human fMRI data were acquired in 23 healthy individuals in a subject- and
observer-blind, placebo-controlled, randomized three-period cross-over study,
as previously reported (Grimm et al., 2015). Subjects were invited in a fixed
interval of 7 days with each scanning session taking place at approximately the
same time of day. Actual measurements took place with a mean interval of
7.7 days (SD: 2.5; range: 4 to 16 days). On each of three scanning visits, and
approximately 60 min prior to the start of the MRI scan, subjects received intra-
venous cannulation followed by an infusion scan via a certified IV pump (Braun
Medical, Melsungen, Germany). Subjects received counterbalanced single in-
travenous doses of either saline (placebo condition), ketamine (0.5 mg/kg body
weight) or scopolamine (4µ g/kg body weight) following previously published
protocols (Furey, Khanna, Hoffman, & Drevets, 2010; Salvadore et al., 2010).
All study participants and personnel involved in the experiments were blind to
the respective substance given. Individual doses of ketamine hydrochloride were
adjusted to body weight (0.5 mg/kg) following previously published protocols
(Diazgranados et al., 2010), diluted in saline, and applied over 40 min. The
placebo condition consisted of a 40-min saline infusion. During the infusion,
subjects were seated comfortably in chair under supervision of a board certi-
fied psychiatrist. To avoid order effects, the sequence of substance applications
was randomly permutated across all 23 participants. MRI scanning took place
after drug administration, with the resting-state measurement starting approx-
imately 20 min after the end of the infusion. The data from the scopolamine
challenge were not analyzed for the current report.
All participants provided written informed consent for the study approved
by the local ethics committee (Medical Faculty Mannheim, University of Hei-
delberg, Germany). A total of 23 participants completed the study (11 female,
mean age 25.13 ± 2.51 years, mean body weight 70.24 ± 11.56 kg, mean height
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Figure 4: Study protocols and methods. (a) Human (light blue): the subjects received
either saline, ketamine or scopolamine via infusion over 45 min, 20 min before each
scanning session. BOLD fMRI resting-state data were acquired and the time series of
270 brain regions were extracted. Correlated, these yielded two correlation matrices
for each subject. (b) Rats (light green): the two groups of animals received either ke-
tamine or saline injection. BOLD resting-state data were acquired before and 15 min
after the injection. The time series of 90 brain regions were extracted and correlated,
resulting in one correlation matrix for each animal. (c) Both human and animals
matrices were thresholded and binarized to extract the underlying topological network
structure. Subsequently, graph metrics such as degree (green lines in the depicted
network), path length (red lines) and clustering coefficient (blue) were computed.
1.75 ± 0.80 meters, mean Body-Mass-Index 22.76 ± 2.71). One subject that ini-
tially participated was excluded from the study, as she was not able to complete
all 3 required MRI measurements.
As this was an exploratory study, no formal power or sample size estimation
was performed. The group size was selected based on prior experience and
literature reports of pharmacological-fMRI studies in healthy subjects, and is
toward the high end of the range of sample sizes typically used.
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3.3.2 Animals and ketamine application
18 Sprague-Dawley male rats (weight: 373-447 g, age 10-11 weeks; Janvier Lab-
oratories, Le Genest-St-Isle, France) were used for fMRI experiments. Animals
were housed under controlled conditions (19-23◦C, 40-60% humidity) with a
12:12 h light-dark cycle (lights on at 7 a.m.).
All procedures were performed according to the regulations covering animal
experimentation within the European Union (European Communities Coun-
cil Directive 86/609/EEC) and within the German Animal Welfare Act and
were approved by the German animal welfare authorities (Regierungspräsidium
Karlsruhe). The rat rs-fMRI data were originally analyzed using a seed-based
approach, the results of which have been reported elsewhere (Gass et al., 2014).
As that study was exploratory in nature, no formal power or sample size es-
timation was performed, but the group sizes (N=9 per group) are toward the
high end of the range typically used in rat fMRI experiments. The exploratory
nature of the experiment was explicitly mentioned in the discussion section of
(Gass et al., 2014) No blinding was done, since for the given type of experiment
it is not possible: ketamine solution had to be prepared before each experiment
depending on the dose.
The experimental design comprised two groups of N=9 rats each. In one
group, S-ketamine (Ketanest R©, Pfizer Pharma GmbH, Berlin, Germany) was
injected subcutaneously at a dose of 25 mg/kg dissolved in saline (total volume
1 ml/kg). The second group received the same volume of vehicle (saline). The
rats were assigned to the groups randomly. The order of ketamine and saline
injections was randomized across animals and time of day. fMRI resting-state
measurements were acquired immediately before and starting at 15 min after
the ketamine/vehicle injection.
These animals represent two groups from the study previously reported (Gass
et al., 2014). The 25 mg/kg group was selected for the present analysis as it
yielded plasma concentrations closest to those obtained in the human study
(Grimm et al., 2015). The rat data were re-analyzed using methods as closely
aligned as possible to those used for the human data (see Fig.1).
3.3.3 Data acquisition and preprocessing - human fMRI
BOLD fMRI was acquired at a 3 Tesla MR scanner (Siemens TIM-Trio, Erlan-
gen, Germany), with the Syngo MR VB17 Software, max. 45 mT/m (z-axis)
and 40 mT/m (x- and y-axis) gradient strength, a 32-channel head-coil, and an
echo-planar imaging (EPI) sequence with full brain coverage with the following
parameters: TR = 1790 ms, TE =28 ms, 34 oblique slices (aligned to the AC-
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PC plane) in descending acquisition order, 3 mm slice thickness, + 1 mm gap,
flip angle = 76◦, FoV = 192 mm, 64x64 matrix, 3x3 mm in-plane voxel size,
and 332 volumes. Preprocessing of functional data consisted of slice time cor-
rection, realignment, and smoothing by a 6mm FWHM Gaussian kernel (FSL
5.0.6) followed by noise correction with the AROMA framework (Pruim et al.,
2015). In short, this includes removal of noise related independent by means
of an automated detection of noise components based on their time course cor-
relation with movement parameters as well as their high frequency fraction
and the overlap of their maps with brain edges and CSF maps (for details see
Pruim et al. (2015)). Data were afterwards corrected for nuisance covariates of
WM and CSF signal as well as the 6 motion parameters obtained during re-
alignment (Pruim et al., 2015). Data were finally normalized to MNI standard
space EPI template (SPM8). 264 whole-brain functional nodes were extracted
from 5mm spheres around coordinates defined by Power et al. (J. Power et al.,
2011). Since the Power atlas does not cover the hippocampus, amygdala and
nucleus accumbens, we included additional six bilateral nodes of interest based
on meta-analytical data (Liu, Hairston, Schrier, & Fan, 2011; Sabatinelli et al.,
2011; Spreng, Mar, & Kim, 2018). In a final step, each node’s time-series was
bandpass filtered at a frequency range of 0.01 to 0.15 Hz.
3.3.4 Data acquisition – rat fMRI
Experiments were conducted at a 9.4 Tesla MRI scanner ( 94/20 Bruker
BioSpec, Ettlingen, Germany) with Avance III hardware, BGA12S gradient
system with the maximum strength of 705 mT/m and Paravision 5.1 software.
Transmission and reception were achieved using a linear whole-body volume
transmitter coil combined with an anatomically shaped 4-channel receive-only
coil array for the rat brain.
Rats were anesthetized under 4% isoflurane (Baxter Deutschland GmbH, Un-
terschleissheim, Germany) in a mixture of N2(70%)/O2(30%). After positioning
in the scanner (head first, prone), 2.5% isoflurane was provided for adjustments.
Then, a bolus of 0.5 ml medetomidine solution (Domitor R©, Janssen-Cilag,
Neuss; 0.07 mg/kg s.c.) was administered; isoflurane was slowly discontin-
ued within the next 10 min, after which a continuous infusion of medetomidine
solution started at 0.14 mg/kg/h rate.
Breathing and cardiac signals were monitored using a respiration pad placed
beneath the chest (Small Animal Instruments Inc., NY, USA) and a pulse
oximeter attached to the hindpaw, respectively. A signal breakout mod-
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ule (Small Animal Instruments Inc., NY, USA) and a 4-channel recorder
(Velleman R© N.V., Gavere, Belgium) were used to record signals (10-ms res-
olution).
The MRI acquisition protocol for each animal comprised a Field Map and
a rs-fMRI measurement. To acquire the rs-fMRI time series, an echo-planar
imaging (EPI) sequence was used with the following parameters: repetition
time/echo time (TR/TE) 1700/17.5 ms, flip angle 60◦, 1 segment, 29 coronal
slices (ascending slice order), 96x96 imaging matrix, field of view 35x35 mm2,
slice thickness 0.5 mm with 0.2 mm inter-slice gap, in-plane voxel dimension
0.365 mm, 300 acquisitions over 8.5 min. The slice stack covered the brain from
the cerebellum to the posterior olfactory bulb.
The preprocessing of the data included correction for field inhomogeneities
(SPM8), regression of movement parameters (FSL, version 4.1), filtering of
respiratory and cardiac signals (Aztec (van Buuren et al, 2009)), slice timing
correction (SPM8) and band pass filtering (0.01 to 0.1 Hz, using Analysis of
Functional NeuroImages (AFNI) software). Additionally the images were spa-
tially normalized (SPM8) to a rat brain template with co-registered atlas in
the Paxinos stereotactic coordinate system (Schwarz et al, 2006) and finally the
signal from CSF was filtered out. A single time-series was extracted for each of
90 anatomically defined ROIs (Schwarz et al, 2006) by averaging single-voxel
time-series over all voxels in a ROI.
3.3.5 Network analysis – humans and rats
Brain networks for humans and rats were constructed by computing the Pear-
son correlation coefficient between the time series extracted from each pair of
regions of interest. The correlation coefficients were transformed to Fisher-
Z-scores. Subsequently, networks were created by binarizing these correlation
matrices. As there is no current consensus on the selection of network density
(fraction of all possible links that is actually present), we computed all graph
metrics over a range of densities (0.05 to 0.2 in steps of 0.01 – for details see
supplemental material) as previously described (Braun et al., 2012; Cao et al.,
2014; Lv et al., 2015; J. Power et al., 2011). The selection of density thresholds
was led by two methodological considerations. On the one hand we wanted our
analysis to be sensitive to subtle alterations in network topology. Due to the
large number of possible connections and the relatively small number of con-
nections actually being different under ketamine, a threshold beyond 0.2 would
significantly impair this sensitivity. One the other hand, given the high degree
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of network fragmentation (i.e. the number of disconnected nodes) at lower den-
sities, we choose a density of 0.05 as the lowest cut-off to ensure a reasonable
degree of connectedness.
This procedure normalizes all networks to have the same number of links
and removes the effect of global differences in correlation strength. Standard
network parameter computation was implemented in MATLAB, using the Brain
Connectivity Toolbox (BCT) (Rubinov & Sporns, 2010). For each subject and
each density level we computed the following network parameters: clustering
coefficient , characteristic path length , small-worldness , and global and local
efficiency . Details on the computation and interpretation of the specific graph
metrics can be found in the supplemental material.
Furthermore we calculated the networks’ motif frequencies, also using func-
tions implemented in BCT, for a sequence of 8 motifs consisting of (undirected)
connections of three to four nodes.
3.3.6 Network Based Statistics – humans and rats
While network analysis can detect changes in the topological organization of
brain networks, we also aimed to test for global differences in absolute con-
nectivity. To that end, we used the Network Based Statistics (NBS) toolbox
(Bullmore & Sporns, 2009; Rubinov & Sporns, 2010) to identify alterations in
specific connections after ketamine application. The NBS deals with the multi-
ple comparison correction for tests by evaluating the null hypothesis on the level
of connected subcluster rather than individually for each connection. Using a
corrected p-level of 0.05, we report the largest connected subclusters identified
by NBS.
3.3.7 Statistical analysis and hypothesis testing
Instead of testing each metric at each density level, we calculated the area un-
der the curve (AUC) for each metric, motif frequency and subject. This yields
density summary estimators for each network metric and avoids the still unre-
solved question of multiple comparison correction in modern network analysis
(Achard, Salvador, Whitcher, Suckling, & Bullmore, 2006). Subsequently, we
tested the AUCs of each metric using paired and independent sample t-tests.
For comparisons in humans a paired t-test was conducted, whereas independent
two-sample t-tests were used for the rats since they consisted of two different
groups. All reported p-values are <0.05, FDR corrected for multiple compar-
isons unless otherwise specified.
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3.4 Results
3.4.1 Alterations of network metrics by ketamine in humans
After application of ketamine, human brain networks showed a decrease in
global and local efficiency compared to placebo (pfdr < 0.05), as well as a
decrease in the small-world coefficient (pfdr < 0.05). An increase of the char-
acteristic path length was found only as trend (p = 0.08). Further, ketamine
induced a significant increase of cyclic motifs (pfdr < 0.05), while the acyclic
motifs were not significantly altered (see 5, 6).
3.4.2 Alterations of network metrics by ketamine in rats
After application of ketamine, the brain networks of rats showed an increase
in clustering coefficient compared to placebo (pFDR < 0.05), as well as an
decrease in the average path length (pFDR < 0.05). This is reflected in the
decrease global efficiency (pFDR < 0.05). Sigma, the small-world coefficient
also decreased (pFDR < 0.05). As in humans, networks after ketamine showed
an increased abundance of cyclic motifs (pFDR < 0.05), but further a significant
decrease of acyclic motifs (see Figures 5, 6).
Figure 5: Topological reconfigurations after ketamine application. Means of area un-
der curve (AUC) for each calculated graph metrics for humans (a) and rats (b) after
saline application (blue) and ketamine (red). Asterisks denote statistically significant
differences (p < 0.05, FDR corrected) between saline and ketamine. C, clustering
coefficient; Eglob, global efficiency; Eloc, local efficiency; FDR, false discovery rate;
L, path length; σ, small-worldness coefficient.
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Figure 6: Area under curves of network motif frequencies for undirected three- and
four-node motifs. For both humans (a) and rats (b), red bars indicate mean values
for the ketamine groups, and blue bars indicate mean values for the controls; aster-
isks denote statistically significant differences between the groups (p < 0.05, FDR
corrected). AUC, area under the curve; FDR, false discovery rate.
To provide further evidence that the observed group differences between saline
and ketamine conditions were indeed induced by the drug challenge (and are not
driven by accidental differences between both groups), we repeated our analysis
in both groups before applications of either ketamine or saline. As expected, we
could not detect any difference between groups in any graph metric (all p > 0.5,
see Figure 8).
3.4.3 Alterations of functional connectivity by ketamine in
humans
NBS revealed a subnetwork consisting of 24 nodes and 24 increased connections
with a T statistic of T > 4.4 induced by infusion of ketamine (pcorrected <
0.05). This subnetwork predominantly comprised regions of the frontal cortex
(∼ 38%), parietal cortex (∼ 33%), as well as occipital (17%) and temporal
cortex (∼ 13%). To further illustrate the importance of specific brain areas
to the large scale reconfiguration observed before, we evaluated the number of
altered connections for each node (see Figure 7). Two frontal areas, namely
frontal superior medial cortex and the middle frontal cortex as well as the mid
cingulate cortex exhibited the highest number of altered connections, identifying
them as being prominently involved in ketamine-induced reconfigurations of
brain networks.
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3.4.4 Alterations of functional connectivity by ketamine in
rats
A subnetwork of 31 edges with a T statistic of T > 5.1 and 21 nodes was identi-
fied in rats after ketamine application (pcorrected < 0.05). Increased connections
could be mainly detected in infralimbic, prelimbic and orbital regions of the
frontal cortex as well as the insular cortex (see Figure 7). Several cingulate and
somatosensory areas also showed increased connectivity. The largest changes
in number of connections occurred in the frontal and insular cortices. As in
humans, the frontal cortex was most strongly affected by ketamine-induced
network reconfiguration.
Figure 7: Alterations of functional connectivity after ketamine application. Ketamine-
related increase in connectivity in humans (left) and rats (right). The line color repre-
sents the statistical significance as indicated by the respective T-statistics. The color
of nodes indicates the number of altered connections for the respective node. The
outer colored circle represents the brain region’s assignment: blue=frontal cortex,
yellow=temporal, red=orbital cortex, green=parietal cortex, magenta =hippocampal
formation. The areas colored in lighter blue stretch along an anterior-posterior axis
compassing multiple brain regions. Human: Cal, calcarine sulcus; F Mid, frontal
middle cortex; O Inf, occipital cortex inferior sulcus; O Mid, occipital cortex middle
sulcus; PaL, paracentral lobule; PCun, precunes; poC, postcentral sulcus; prC, pre-
central sulcus; SMA, supplemental motor area; T inf, temporal cortex inferior sulcus;
T sup, temporal cortex superior sulcus. Rat: Au, auditory cortex; Cg1, cingulate cor-
tex; HcSDG, hippocampus subiculum/dentate gyrus; I, insular cortex; IL, infralimbic
cortex; M2, secondary motor cortex; OF, orbitofrontal cortex; Pir, piriform cortex;
PL, prelimbic cortex; S2, secondary somatosensory cortex; TeA, temporal association
area; V, visual cortex. Subscript indicates left (l) or right (r) hemisphere.
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3.5 Discussion
Human and rat brains, despite all their differences, have shown some remarkable
similarities in the spatial, functional and topological characteristics of intrinsic
network architecture (Kaiser & Varier, 2011; Schwarz, Gass, Sartorius, Zheng,
et al., 2013; Schwarz, Gass, Sartorius, Risterucci, et al., 2013). Network anal-
ysis has been proposed as a promising tool for translational neuroscience and
especially cross-species drug discovery (Smucny et al., 2014), but studies uti-
lizing the translational power of these approaches (De Vico Fallani, Richiardi,
Chavez, & Achard, 2014; Smucny et al., 2014) are rare.
Here, we used network analysis to study the global topological reconfiguration
of human and rat brain networks in response to a pharmacological challenge
with sub-anaesthetic doses of ketamine.
3.5.1 Consistent reconfiguration of brain networks in humans
and rats
After ketamine infusion, brain networks in both humans and rats showed an
increase in overall connectivity, consistent with the results from previous studies
(Anticevic et al., 2015; Driesen et al., 2013; Khalili-Mahani et al., 2015). In both
species, the frontal cortex showed particularly prominent connectivity changes,
which may be related to our previous findings of altered prefrontal-hippocampal
connectivity (Grimm et al., 2015). Regarding the other affected brain regions,
between-species concordance was incomplete. However, it should be noted that
NBS is suitable for identifying cluster-wide connectivity changes, not for making
inferences on specific connectivity pairs. This precludes detailed interpretation
of the individual regions displaying altered connectivity in our data.
The connectivity increase was accompanied by a topological reconfiguration
of large-scale brain networks towards a conformation characteristic of less inte-
grated and more segregated information processing, as evidenced by decreases
in global efficiency and a decrease in small-worldness. A higher abundance of
cyclic motifs points towards a network organization more tuned to local pro-
cessing and less suitable for efficient long range communication in both species.
This is further supported by the decreased occurrence of acyclic motifs in rats,
although this finding wasn’t significant in humans. In line with a previous
study using a different imaging modality, cross-animal correlations rather than
within-subject temporal correlations and a different NMDA receptor antago-
nist (Dawson et al., 2014), we observed a loss of small-worldness properties
after ketamine injection. Our study therefore adds further support to the idea
of a compromised functional integration in NMDA receptor dysfunction mod-
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els of disease. It is interesting to note that a previous study from our group
using the same human and rat data as in the current work reported an in-
creased prefrontal-hippocampal coupling after NMDA receptor blockade to be
a cross-species phenotype altered by ketamine (Grimm et al., 2015).
Although a direct statistical comparison between species would be misguided
for several reasons, the placebo-controlled design of both studies enabled us
to compare findings between species qualitatively. Overall, we found highly
concordant and directionally consistent network reconfiguration in humans and
rats. In both species we observed an increased total connectivity. Topologically
we detected a less globally integrated and more segregated network architecture
following ketamine administration.
3.5.2 Discrepant findings in humans and rats
Interestingly, while motif analysis revealed a significant increase of cyclic motifs
after ketamine infusion in both species, we found no difference in the clustering
coefficient in humans. This might be a consequence of triangles being introduced
primarily around nodes with a high degree, for which the clustering coefficient
is less sensitive due its normalization by the number of all possible triangles.
Surprisingly, in rats we observed a decrease in path length after ketamine
application, contrasting with effects on other parameters indicating a less inte-
grated network architecture. However, this might be a result of our focus on
sparsely connected networks, which often suffer from a higher fragmentation to
which the characteristic path length (in contrast to global efficiency) is very
prone.
3.5.3 Relation to mental disorders
Interestingly, the network reconfigurations identified here are opposite to net-
work alterations in depressed patients, who show increased global efficiency
and small-worldness compared to healthy controls (Q. Gong & He, 2015; Zhang
et al., 2011). We hypothesize that this may indicate a network mechanism
supporting the action of ketamine as rapidly acting antidepressant. This idea
is further supported by a previous study showing ketamine effects on network
topology opposite to those observed in depressed subjects (Lv et al., 2015).
Studies investigating brain network properties in schizophrenia consistently
report reduced total connectivity as well as higher integration (e.g. increased
local efficiency, decreased characteristic path length) and less local processing
(e.g. decreasing clustering coefficient and local efficiency) (Braun et al., 2015;
Fornito, Zalesky, Pantelis, & Bullmore, 2012). These findings are in contrast
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to the observed network reconfigurations in our data, suggesting that acute
ketamine application rather resembles a different glutamatergic state than ob-
served in chronic schizophrenia.
3.5.4 Limitations
Despite our efforts to align protocols of the human and rat studies, there still
remain some differences. First, ketamine was applied differently – subcuta-
neous bolus injection in rats versus intravenous continuous infusion in humans
– and therefore might evoke different biological responses. Further studies are
urgently needed, as application protocols might explain clinically diverse effects
and could account for the heterogeneous results in previous human (Driesen et
al., 2013; Scheidegger et al., 2012) and rat (Gass et al., 2014) studies. Second,
in rats anesthesia as well as interactions of the anesthetic agent with ketamine
might also influence the behavior of brain networks, although previous studies
have shown a high correspondence of human and rat functional brain networks
(Bähner et al., 2015; Grimm et al., 2015). A further potential limitation re-
sults from the different number of nodes used in humans and rats. However, by
choosing a proportional thresholding approach, we aimed at examining changes
in network architecture independent of the absolute number of links in a given
network. Due to the thresholding approach our results are specific to the chosen
range of network densities (5% to 20%) which surely is not the only possible
choice of densities. Along with network size the composition of nodes is a possi-
ble restriction to comparability. While in humans 90% of the nodes are cortical,
in rats the fraction is considerably smaller (40%), which reflects the substan-
tially developed and differentiated cortex in humans. Despite this asymmetry
in the fraction of cortical nodes, the results in both species can be compared
thanks to the placebo-controlled design of the study in both species. We com-
pare changes in network organization qualitatively rather than absolute quan-
tities of network metrics in both species. Moreover, a closer look at the brain
regions which experience most significant change in connectivity and number
of connections reveals that in rats as well as humans effects of ketamine occur
(almost) exclusively in cortical regions (see Fig 4). Another potential confound
is the influence of the CBF increase induced by ketamine (Långsjö et al., 2003).
The BOLD signal correlation changes we observed could include contribution
from CBF increase per se or the differences in correlation may be modulated by
CBF increase. Regrettably we did not measure CBF independently and there-
fore cannot access its impact on network results. Given the promising results
on ketamine effects on functional connectivity in this study (and others in re-
cent literature), further studies examining the effect of CBF are recommended.
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Finally, while the animal study had a two-group design, the human study was
designed as a placebo-controlled double-blind cross-over study. The missing
control for between-subject variance in the animal study might account for the
observed higher differences in rats, but a comparison between groups before
ketamine applications revealed no differences between network parameters (see
supplemental material).
3.5.5 Relevance for translational research and drug discovery
These findings are encouraging for translational research and its application
to drug discovery. The use of global brain parameters reflecting functional
network topology has the advantage of reducing complex, high-dimensional
imaging data to a few summary measures, reducing the multiple comparisons
burden and avoiding the need to pre-specify specific brain regions or connec-
tions. The latter is valuable, and the involvement of specific brain systems is
important to increase biological understanding, but can be difficult to apply
with confidence, especially when dealing with novel compounds or mechanisms.
Global brain network parameters may thus represent a more robust endpoint
for translational functional imaging at the early phase of drug discovery and
development. Importantly, the similarities in the pharmacological effects across
species suggest that preclinical experiments can be used to inform early clinical
phase biomarker studies. That said, the differences in the observed effects serve
as a reminder that effects in humans are unlikely to be a perfect simulacrum
of those observed in preclinical setting. This observation is consistent with
other recent translational pharmacological imaging studies, where consistency
between rodent and human effects was high but not complete (Becerra et al.,
2013).
Another important caveat is that ketamine is a highly psycho-active com-
pound. Novel compounds being developed as potential medicines are unlikely
to induce such strong subjective effects per se, and their effects on brain func-
tional connectivity may be more subtle. The sensitivity of network topology
measures to a broader range of compounds and mechanisms remains to be es-
tablished. However, as a pharmacological model of a hyperglutamatergic state,
ketamine-induced changes in functional connectivity may serve as an exam-
ple of brain function perturbation that can be reversed by pre-treatment with
compounds of interest (Doyle et al., 2013; Joules et al., 2015). Finally, the sen-
sitivity of results to methodological aspects such as brain parcellation scheme,
image post-processing variations, choice of connectivity metric and thresholding
or weighting scheme remains an important area of investigation.
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3.6 Conclusions
Using network analysis and task-independent brain imaging, we observed highly
concordant cross-species topological reconfigurations of large scale brain net-
works induced by acute ketamine administration in rats and humans. These
changes indicated a pharmacologically-induced shift towards a more segregated,
less integrated network conformation, and are opposite in valence to network
topology changes observed in depressed subjects.
In conclusion, our results demonstrate the potential of these novel techniques
for the identification of translational biomarkers for drug discovery.
3.7 Supplementary Information
3.7.1 Methods
Threshold selection
As there is no current consensus on how to select network thresholds in graph
theoretical analysis, we chose the network density as the threshold according to
previous studies (1-4). In short, each connectivity matrix was thresholded over
a range of densities, taking into account only the respective percentage of abso-
lute highest correlations or links. The choices of the density range (5% to 20%
of the connections) was determined by two methodological considerations: i)
given the high number of possible connections (for humans: 270*269/2 = 36315;
rats: 90*89/2 = 4005), we wanted to be sensitive enough to subtle alterations.
If, for example as in our human dataset, about 400 connections are different
between conditions, at a density of 20% ( = 7236 absolute connections) only
(400/7236*100 = ) 5% of the considered connections are altered. Therefore, in-
creasing the density beyond 20% would significantly impair our ability to detect
topological difference between conditions. ii) given the high degree of network
fragmentation (i.e. the number of disconnected nodes) at lower densities, we
choose a density of 5% as the lowest cut-off to ensure a reasonable degree of
connectedness.
Network-based Statistics
Network-based statistic (NBS) was used to identify clusters of functional links
that are altered after applications of Ketamine. NBS is a method to effectively
control cluster-level family-wise error (FWE) for link-wise matrical comparisons
and offers a larger power than mass-univariate tests on independent links (5,
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6). Consistent with prior studies (5-8), we applied initial directed paired t-
tests for the human data to each of the N(N-1)/2 = 36315 (N=270) links in
the connectivity matrices and initial directed t-tests for the rat data to each of
the N(N-1)/2 = 4005 (N = 90) links in the connectivity matrices respectively,
thereby generating a P-value matrix representing the probability of accepting
the null hypothesis for each link.
All links with T-statistics of T > 4.4 (humans) and T > 5.1 were then thresh-
olded into a set of suprathreshold links (8), and connected clusters within this
set were identified by breadth first search (9). The significance of the identified
clusters was tested by permutation testing, where i) sessions were randomly at-
tributed for each subjects in the human dataset, and ii) in the rat dataset, the
rats were randomly reallocated into one of the two groups and the maximal size
of the identified cluster was recalculated during each of the 5000 permutations.
The corrected P value for the cluster was determined by the proportion of the
derived cluster sizes in the permutation distribution that were larger than the
observed group difference.
Statistical analysis
Prior to inference analysis, we thoroughly tested if our data met the assump-
tions of the tests (e.g., normal distribution) using the Kolgmorov-Smirnov Test
for normality. As all test revealed no significant violation of the normality
assumption, we subsequently proceeded using parametric tests (see Table 1).
Further, equal variance was tested by Levene’s test for inequality. If not satis-
fied, p-values for the non-equal variances estimates are reported.
3.7.2 Results
Group differences in rats before substance application
To show that the observed group differences between saline and ketamine condi-
tions are indeed induced by the drug challenge (and are not driven by differences
between both groups), we repeated our analysis of both groups before appli-
cations of either ketamine or saline (see Figure 8). As expected, we could not
detect any difference between groups in any graph metric (all p>0.5, see Figure
8).
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Table 1: p-values for the comparisons Kolmogorov-Smirnov test for normality
Humans Rats
placebo ketamine
clustering 0.977 0.995 0.352
path length 0.842 0.713 0.689
sigma 0.443 0.719 0.179
Eglob 0.800 0.255 0.935
Eloc 0.607 0.936 0.927
motif_31 0.697 0.564 0.787
motif_32 0.351 0.476 0.994
motif_41 0.580 0.360 0.917
motif_42 0.872 0.643 0.560
motif_43 0.980 0.996 0.961
motif_44 0.985 0.935 0.660
motif_45 0.713 0.801 0.831
motif_46 0.207 0.340 0.998
Figure 8: Comparison of graph metrics in both rat groups before application of saline
or ketamine. No difference between the saline (blue) and ketamine (red) group could
be detected for any of the tested graph metrics. All p > 0.5 before corrections for
multiple comparisons.
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Effects of bandpass filter
To increase comparability between species, we repeated our analysis of the hu-
man fMRI data with exactly the same bandpass filter used in the animals ((0.01
to 0.1 Hz). We found only marginal effects on the observed reconfiguration pat-
tern induced by Ketamine on brain networks (see Table 2 and Figure 9).
Table 2: p-values for the comparisons of areas under the curve for the tested network
metrics. Asterisk (*) indicates significance after correction for multiple comparisons
using the false discovery rate
Network metric Animals
(0.01-0.1 Hz)
Humans
(0.01-0.15 Hz)
Humans
(0.01-0.1 Hz)
Clustering
coefficient
p = 0.0249 * p = 0.2925 p = 0.4963
Path length p = 0.0208 * p = 0.0896 p = 0.0566
sigma p = 0.0249 * p = 0.0042 * p = 0.0047 *
Global efficiency p = 0.0013 * p = 0.0189 * p = 0.0148 *
Local efficiency p = 0.7336 p = 0.0241 * p = 0.0310
Figure 9: Comparison of graph metrics in humans after saline and ketamine for
different frequency bands. Area under curves for each calculated graph metrics for
humans with a bandpass filter of 0.01 to 0.15 Hz (A) and 0.01 to 0.15 Hz (B) after
saline application (blue) and ketamine (red). Asterisks denote statistically significant
differences (p<0.05, FDR corrected) between saline and ketamine. C = clustering
coefficient, L = path length, σ = small-worldness coefficient, Eglob = global efficiency,
Eloc = local efficiency.
33
Chapter 3 Translational Study on Ketamine
Effect of age
To explore the impact of age on the observed network reconfiguration induced
by ketamine, we correlated the differences in AUCs between saline and ketamine
with age.
In humans, we could not detect any significant correlation with age (all p >
0.25, all r < 0.25), with either Pearson and Spearman correlation.
Additional NBS analyses
For each group, we first assessed the connectome differences by using a simple
FDR correction approach as implemented in the NBS toolbox. In humans, we
found 215 significant edges at a FDR-corrected p-level of 0.05, 212 edges at
a FDR-corrected p-level of 0.01 and 157 edges FDR-corrected p-level of 0.001.
Analogous, in rats, we found 248 significantly different edges at a FDR-corrected
p-level of 0.05, 120 edges at a FDR-corrected p-level of 0.01 and 120 edges at a
FDR-corrected p-level of 0.001.
To find a set of interpretable edges, we then systematically explored the
connectomic difference starting with an initial T-threshold of T > 3.5 in human
and rats. This yielded 187 significantly different edges in rats and 206 edges
in human, respectively. The last significant T-threshold could be identified as
being T > 7.3 in rats with one connections survived at p = 0.006 and T > 4.5
in humans with 6 edges surviving correction at a p-level of 0.042.
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4
Study: NMDA receptor
antagonists traxoprodil and
lanicemine improve
hippocampal-prefrontal coupling
and reward related networks in rats
This chapter was submitted for publication to Neuropsychopharmacology and
is currently under review (Becker et al., submitted).
4.1 Abstract
The N-methyl-d-aspartate receptor (NMDAR) antagonists traxoprodil and lan-
icemine are candidate antidepressant drugs with fewer side effects than ke-
tamine. In order to understand their mechanism of action, we investigated
their acute effects on brain connectivity using resting-state functional magnetic
resonance imaging (rs-fMRI).
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Functional connectivity (FC) alterations were examined using interregional
correlation networks. Furthermore, graph theoretical methods were used for
analysis of whole brain FC networks. As the interest in NMDAR antagonists as
potential antidepressants was triggered by the antidepressant effect of ketamine,
results were compared to previous findings from ketamine studies. Similarly to
ketamine but to a smaller extent, traxoprodil increased hippocampal-prefrontal
(Hc-PFC) coupling. Unlike ketamine, traxoprodil decreased connectivity within
the prefrontal cortex (PFC). Lanicemine had no effect on these properties. Con-
nectivity changes overlapping between the drugs as well as alterations of local
network properties occurred mostly in reward related regions.
The improvement of Hc-PFC coupling corresponds well to clinical result,
showing ketamine to have a greater antidepressant effect than traxoprodil, while
lanicemine has a weak and transient effect. Thus, it can be concluded that
the antidepressant effect of NMDA antagonists at least partly originates from
enhanced hippocampal-prefrontal coupling. The effects on local network prop-
erties and regional connectivity suggest that improvement of reward processing
might also be important for understanding the mechanisms underlying the an-
tidepressant effects of these drugs.
4.2 Introduction
The non-selective, non-competitive NMDA receptor antagonist ketamine has a
rapid antidepressant effect, even in treatment resistant patients, if continuously
applied at low doses for 45 min, iv (Berman et al., 2000; Zarate et al., 2006).
However, its antidepressant action comes at the price of dissociative side effects
which prevent a broader clinical use of ketamine (Vollenweider & Kometer,
2010). Alternative antidepressant drugs with fewer side effects could possibly
be found among other NMDA receptor antagonists.
Lanicemine (AZD6765) is a low-trapping channel blocker inducing channel
closure while it is bound to a site inside the channel (Mealing, Lanthorn, Mur-
ray, Small, & Morley, 1999). The degree of trapping correlates with the severity
of side effects: the higher the trapping, as in e.g. ketamine (86% of trapping),
the more severe the side effects. Lanicemine exhibits 54% of trapping and has an
improved safety profile (Mealing et al., 1999). It produces rapid but transient
antidepressant efficacy (Zarate et al., 2013), as well as sustained antidepres-
sant effect after repeated administration (Sanacora et al., 2014), both without
psychotomimetic or dissociative side effects.
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Traxoprodil (CP-101,606) is a negative allosteric modulator of the NR2B
subtype NMDAR. There is evidence that the antidepressant effect of ketamine
is caused by its action on the NR2B-containing NMDAR (Miller et al., 2014).
Thus, drugs exclusively antagonizing the NR2B subunit of NMDAR could be
promising candidates for new antidepressants. Traxoprodil has rapid antide-
pressant effects with nearly no dissociative reactions with efficacy lasting for ≈
1 week (Preskorn et al., 2008).
Two candidate drugs are examined in this study with regard to their effects
on functional brain connectivity and network organisation, using rs-fMRI, as
in recent years psychiatric disorders including depression are increasingly seen
as disorders of the functional connectome (Artigas et al., 2017; Braun et al.,
2015; Q. Gong & He, 2015; Sporns, 2011). Despite the differences caused by
the heterogeneity of the disease and variations in the patient groups, there
are results recurring across studies including improved network integration and
impaired connectivity of reward related regions (L. Gong et al., 2017; Q. Gong
& He, 2015). Rs-fMRI is widely used for investigation of functional changes
induced by pharmacological challenges. Whole brain functional networks are a
useful representation for detection and comparison of drug effects across studies
and species (Becker et al., 2016; Gass et al., 2018; Gass et al., 2014; Grimm
et al., 2015; Tang et al., 2018).
We aimed for results comparable to those of previous studies on ketamine,
which found increased hippocampal-prefrontal as well as intra-PFC connectiv-
ity along with reduced network efficiency and small-worldness (Becker et al.,
2016; Gass et al., 2014; Grimm et al., 2015). Considering that ketamine shows
greater antidepressant effect than traxoprodil or lanicemine in clinical studies,
we expected to find similar but less pronounced effects.
4.3 Methods
4.3.1 Animals
82 male Sprague-Dawley rats were used in this study. Animal experiments were
conducted following the regulations of the European Union (European Commu-
nities Council Directive 86/609/EEC) as well as the German Animal Welfare
Act and were approved by the responsible authorities (Regierungspräsidium
Karlsruhe).
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4.3.2 Drugs
Traxoprodil and lanicemine were provided by Boehringer Ingelheim Pharma,
Ingelheim, Germany. The doses were selected in order to achieve 0.3, 1 and 3
times the exposure measured in clinical studies of traxoprodil (Johnson, Shah,
Jaw-Tsai, Baxter, & Prakash, 2003; Preskorn et al., 2008; Taylor et al., 2006)
and lanicemine (Guo, Zhou, Grimm, & Bui, 2015; Sanacora et al., 2014).
Table 3: Concentrations of drug solutions, target doses, and group sizes.
Concentration
(mg/ml)
Dosage
(mg/kg)
Number
of animals
0.52 1.04 11
Traxoprodil 1.7 3.4 11
5.2 10.4 11
0.6 1.2 13
Lanicemine 2 4 12
6 12 13
Control - - 11
Since the essential quantity for comparable effect size is the unbound plasma
concentration of the compound, differing plasma protein binding (PPB) be-
tween humans and rats had to be accounted for. For lanicemine the PPB in
rats was found to be higher than in humans (47% vs. 33%). Using clinical
pharmacokinetic data and pharmacokinetic measurements conducted in rats,
the temporal development of plasma concentrations of the drugs was simu-
lated by pharmacokinetic modelling. PK model development and parameter
estimation was performed using Phoenix WinNonlin 6.4, NLME 1.3 (Certara,
Princeton, New Jersey, USA). Built upon these investigations, the concentra-
tions necessary for comparable exposures in rats 40 minutes after subcutaneous
injection were determined.
The actual dosage of the drugs followed from the volume of 2 ml/kg injected
during each measurement. The concentrations, the according doses, and the
group sizes are shown in 3.
The control group received the 2 ml/kg volume of the vehicle substance,
dimethyl sulfoxide (DMSO).
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4.3.3 Resting-state fMRI
MRI measurements were performed on a 9.4 T small animal scanner (Bruker
Biospec, Avance III hardware, Paravision 6 software, Bruker Biospin, Ettlingen,
Germany). Before each fMRI measurement a T2-weighted structural image
(RARE, TR/TE = 1200/50ms, 0.15 mm isotropic resolution) and a fieldmap
(double gradient echo, TR = 20ms, TE = 1.7ms/5.7ms) were recorded.
For each animal a 50 min fMRI was recorded (EPI sequence TR/TE =
1500/17.5ms, 0.365mm in plane resolution, 0.5 mm slice thickness). Drugs
were injected 10 min after the beginning of each fMRI measurement. Thus,
after a 10 min baseline period the fMRI scan covered 40 min post-injection for
examination of acute drug effects.
Respiratory and cardiac signals were acquired using a respiration pad placed
beneath the chest (Small Animal Instruments, Stony Brook, NY, USA) and
a pulse oximeter attached to the hind paw, respectively. During the fMRI
measurement these signals were recorded (100 Hz sampling rate) for later use
in data processing.
We applied the same anesthesia protocol as in previous studies (Gass et al.,
2018; Gass et al., 2014). Anesthesia was initiated by 4% isoflurane (Baxter
Deutschland, Unterschleissheim, Germany), then maintained at 2.5%, 30 min
before the beginning of the EPI, a bolus of medetomidine (Domitor, Janssen-
Cilag, Neuss, Germany) was injected (0.07 mg/kg s.c.) and isoflurane was
slowly discontinued. Stable sedation was ensured by continuous infusion of
medetomidine (0.28 mg/kg/h, s.c.).
4.3.4 Image preprocessing
Data preprocessing included realignment, unwarping, slice time correction
(SPM), filtering of respiratory and cardiac signals (Aztec (van Buuren et al.,
2009)), RETROICOR (Glover, Li, & Ress, 2000)).
For correction of artifacts related to subject movement, we used an approach
based on independent component analysis (ICA) (Hyvärinen et al., 2001), which
has been previously used for denoising fMRI data (Kelly et al., 2010). We
chose an automatized approach to distinguish noise from non-noise components
similar to ICA-AROMA (Pruim et al., 2015). Finally, the data were bandpass-
filtered in the range of 0.01 Hz to 0.1 Hz (AFNI).
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4.3.5 ROI-ROI connectivity
Average regional time courses were extracted from the preprocessed data a.
Forty-six regions were defined using the rat brain atlas by Schwarz et al. (2006).
All calculations were performed using MATLAB unless stated otherwise.
In order to achieve optimal comparability to a previous study on ketamine
(Gass et al., 2014), we extracted three blocks of 400 time points (600 sec) each
from the whole series of 2000 time points (3000 sec): one from the beginning of
measurement (before drug injection) and two more 15 and 30 min after injec-
tion, respectively. For each set of regional time courses, ROI-ROI connectivity
matrices were calculated as pairwise Pearson’s correlation coefficients leading
to three connectivity matrices per measurement. In order to examine changes
in functional connectivity induced by the drug injection, we calculated differ-
ence matrices between both post-injection and pre-injection matrices for each
subject. The effects of drug dosage and post-injection delay were investigated
by two-way ANOVA using drug dosage and post-injection time as factors for
each drug separately. Effects of each of the drug groups compared to the con-
trol group were investigated by post-hoc tests using the Tukey-Kramer method.
For a direct comparison with previous studies on ketamine (Gass et al., 2014;
Grimm et al., 2015), we regarded a subnetwork consisting of prefrontal and
hippocampal regions.
4.3.6 Network analysis
First we normalized the connection weights by the individual maximum value
and thresholded the connectivity matrices by preserving the strongest edges
(20th to 45th percentile, 5% increment). We chose a relatively high minimum
density of 20% to maintain sufficient connectedness. At 20% density less than
10% of nodes were disconnected from the rest of the network. 45% was the
highest density with no negatively weighted connections included.
For each subject and each density threshold we calculated several graph theo-
retical properties of the individual networks using the Brain Connectivity Tool-
box (Rubinov & Sporns, 2010, 2011): degree, betweenness centrality, local and
global efficiencies, characteristic path length, clustering coefficient, and small
world index.
The clustering coefficients and path lengths as well as global and local ef-
ficiencies were normalized by the according quantities calculated for a null
model, a network generated by randomizing topology while preserving degree
and strength distributions (Rubinov & Sporns, 2010, 2011).
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Since the choice of an individual threshold is arbitrary we calculated the areas
under the curve (AUC), i.e. the averages over the range of thresholds.
Focusing our analysis on the changes in the brain networks induced by the
drugs, we subtracted the AUC values of the baseline datasets from those of
the post-injection data. Thus we obtained two sets of differences, subsequently
called ∆-values, for each subject (15 min – pre-injection, 30 min – pre-injection).
Effects of the drugs on these ∆-values were examined by two-way ANOVA (dose
and post-injection time points as factors), followed by post-hoc tests using the
Tukey-Kramer method.
4.3.7 Exposure-response relationships
Directly after the fMRI measurements, a blood sample was taken from
each rat by cardiac puncture to determine the actual drug exposure in the
plasma. Exposure-response relationships between drug plasma concentrations
and ∆-values of global network metrics were assessed by pharmacokinetic-
pharmacodynamic (PK-PD) modelling (Meibohm & Derendorf, 1997). We fit-
ted an Emax-model to the network metric differences ∆z and the concentrations
c:
∆z = ∆zmin +
∆zmax −∆zmin
1 + 10log(C50)−log(c)
4.4 Results
4.4.1 Hippocampal-prefrontal subnetwork
Results of the post-hoc tests for connectivity in the Hc-PFC subnetwork are
shown in Figure 10. For comparison we generated according graphs using the
data from our previous ketamine study (Gass et al., 2014). Post-hoc tests were
performed for connections showing significant main effects of dose (p < 0.05).
Traxoprodil at the high dose strengthened many connections between hip-
pocampal and prefrontal regions. At the low and medium doses connections
within the PFC were weakened. Lanicemine caused partly overlapping but
fewer significant changes. At the high and low doses intra PFC connectivity was
decreased, at the medium dose retrosplenial-hippoocapmal connectivity was in-
creased. As previously reported, ketamine strengthened hippocampal-prefrontal
coupling as well. In contrast to the drugs investigated here, it enhanced intra
PFC connectivity.
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Figure 10: Effects on Hc-PFC network: Significant results of post hoc tests (Tukey-
Kramer method, p<0.05) between control and each of the dose groups. Colors
represent mean group differences of ∆-values in Pearson correlation coefficients.
Only connections with significant (p<0.05) effect of dose in the ANOVA were
considered in the post hoc tests. Thicker lines indicate significance after FDR
correction. Ketamine results are shown for comparison and were obtained from the
data of our previous study (Gass et al., 2014).
(Cg1/2: cingulate cortex, OF: orbitofrontal cortex, IL/PL: infra-/prelimbic
cortex, HcAD/SDG/V/PD: Hippocampus (anterior-dorsal/subiculum-dentrate
gyrus/ventral/posterior-dorsal), RS: retrosplenial cortex)
4.4.2 Overlapping effects
Despite the strong differences in results between drugs and doses, there were
several connections consistently altered by various doses of both drugs (Figure
11) Effects were considered overlapping, if they were significant and in the same
direction in at least three of the six comparisons to the control group and in at
least one comparison for each substance. Significance for the individual group
comparisons is summarized in the table included in Figure 11.
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Figure 11: Overlapping effects of traxoprodil and lanicemine: Connections are shown
if an effect was found in at least half of the groups compared to controls and at least
one group for each substance. Colors represent the number of group comparisons
showing significant differences with the sign referring to the direction of the effect
compared to the control group. The groups contributing to the overlapping effect are
indicated in the table on the right.
(OF: orbitofrontal cortex, ON: olfactory nucleus, IL: infralimbic cortex, Cg2: cingu-
late cortex, Acb: nucleus accumbens, RS: retrosplenial cortex, V: visual cortex, Tu:
olfactory tubercle, ZI: zona incerta, HcV/HcPD: ventral/posterior dorsal hippocam-
pus, SC/IC: superior/inferior colliculus, DLT: dorsal lateral thalamus, DRN: dorsal
raphe nucleus)
Despite the different patterns of connectivity changes induced by both drugs
there were no directly contradicting effects, i.e. connections significantly in-
creased by one but decreased by the other drug.
4.4.3 Network properties
The differences of network properties and the results of the ANOVA and post
hoc tests are summarized in Figure 12.
Global metrics
The low dose of traxoprodil significantly increased global efficiency and de-
creased characteristic path length, indicating improved network integration. In
contrast, the high dose had the opposite effect.
There was no significant effect of any dose of lanicemine on any of the global
network metrics. Despite the lack of significance, lanicemine did not show
fundamentally different effects for different doses.
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The effect of ketamine on global graph metrics clearly increased with the dose.
For the high dose we found a loss of efficiency and small-worldness indicating
decreased network integration.
None of the drugs had significant effects of post-injection time.
Local metrics
There were significant differences between the drug groups and the control group
for local network properties of several regions. Again the results for the different
doses of traxoprodil were clearly different without directly contradicting each
other. The medium dose induced a decrease in the degree of the retrosplenium,
whereas it increased the betweenness centrality index (BCI) of dorsolateral tha-
lamus (DLT), amygdala, and anterior dorsal (HcAD). It also increased the local
efficiency of the dorsal raphe nucleus (DRN). The effects of the high and low
doses were very different from those of the medium dose, while being relatively
similar to each other, e.g. increased degree of the cingulate cortex (Cg1), de-
creased local efficiency of olfactory tubercle (Tu) and globus pallidus. Similar
to the medium dose, the high one increased BCI in the amygdala and HcAD.
In contrast, the low dose reduced the efficiency of the amygdala.
Lanicemine exhibited more consistent effects across doses. BCI of the retros-
plenium was increased by all doses. The medium dose also reduced degree and
local efficiency of globus pallidus as well as degree of nucleus accumbens and
increased the degree of DLT. The effects of the low dose were generally in line
with those of the medium dose, whereas the high dose showed an increase in
local efficiency of nucleus accumbens and BCI of globus pallidus.
The globus pallidus was the only region where a direct overlap of the results
for both drugs could be found.
4.4.4 PK-PD-models
Fitting of PK/PD models was successful for most network metrics in both
groups. Figure 13 shows ∆z-log(c) plots for traxoprodil and lanicemine. Con-
sistent with the dose-based analyses described above, exposure response rela-
tionships were more pronounced in the traxoprodil than the lanicemine group
and there was no difference between measurement timepoints (according figure
for 15 min measurement in supplementary material, Figure 15). The Emaxmax-
model fits indicate increased characteristic path length and decreased global
efficiency in response to traxoprodil. Exposure to lanicemine caused an increase
in characteristic path length and a decrease in small-worldness.
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4.5 Discussion
4.5.1 Hippocampal – prefrontal connectivity
We expected traxoprodil and lanicemine to affect connectivity in the Hc-PFC
subnetwork. Hc-PFC coupling is supposed to be critically involved in a variety
of psychiatric disorderes including depression (Godsil, Kiss, Spedding, & Jay,
2013; Sampath, Sathyanesan, & Newton, 2017). The similarity of findings for
traxoprodil and ketamine might reflect the antidepressant effect shared by both
drugs. Lanicemine did not affect Hc-PFC coupling, which possibly reflects its
limited clinical efficacy.
Connectivity within the PFC was decreased by traxoprodil in contrast to
what was found for ketamine. Lanicemine also decreased intra PFC connec-
tions, but to a smaller extent than traxoprodil. Decreased intra-prefrontal
connectivity is observed in unmedicated depressed patients (Geng et al., 2016;
Scheinost et al., 2018). The absence of intra-PFC hyperconnectivity in response
to traxoprodil and lanicemine can explain the lack of dissociative side effects,
but it might also explain lower antidepressant efficacy. It is highly probable,
that dissociative effects are part of the same neurocircuitry as antidepressant
effects and both cross in the PFC (Luckenbaugh et al., 2014).
4.5.2 Overlapping effects
The decrease of intra PFC connectivity induced by both drugs in contrast to
ketamine, is reflected in an overlapping decrease of connectivity between the
cingulate cortex (Cg2) and the medial PFC (IL). Most of the parallel effects of
both drugs were related to reward circuitry. Connectivity between the nucleus
accumbens (Acb), a hub of the reward system and retrospleninial cortex (RS),
the homologue of human precuneus/posterior cingulate cortex in the rat, was
found to correlate with severity of depression (L. Gong et al., 2017) and spec-
ulated to reflect a compensation for impaired reward processing (Hwang et al.,
2016). Our observation of reduced FC between these two regions might reflect
a pro-hedonic effect of these drugs.
The inferior colliculus (IC) belongs to the brain aversion system, where it
gates acoustic information and filters sounds that require immediate action in-
tegrating information of aversive nature(de Oliveira, Colombo, Muthuraju, Al-
mada, & Brandao, 2014). Increased connectivity between IC and orbitofrontal
cortex (OF), a region implicated in the learning of stimulus-outcome relation-
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ship and cognitive flexibility, might improve cognitive control of defensive es-
capist and fearful reactions and the deficient cognitive flexibility characteristic
for depression.
The superior colliculus (SC), in addition to its direct involvement in visual
function, also belongs to the brain aversion system. The visually responsive
cells in SC are modulated by reward learning (Vuilleumier, 2015) and SC re-
ceives projections from the dorsal raphe nucleus (DRN), suggesting that DRN
exerts a coordinating influence on the visual system (Villar, Vitale, Hokfelt, &
Verhofstad, 1988). Also glutamatergic neurotransmission in the DRN regulates
serotonin transmission (Soiza-Reilly & Commons, 2011). Thus, increased con-
nectivity between DRN and SC could improve an affective influence on visual
orientation and perception through serotonergic neurotransmission, deficient in
depression.
Both drugs elevated connectivity between olfactory tubercle (Tu) and zona
incerta (ZI). Tu is part of the ventrostriatal reward system and its stimulation
directly promotes reward (Fitzgerald, Richardson, & Wesson, 2014). ZI is in-
volved in limbic-motor integration and deep brain stimulation near or in the ZI
alleviates anxiety and depression (Burrows et al., 2012). Therefore, an upregu-
lation of the connectivity between Tu and ZI might improve reward behaviour
and reward-related motor control.
Increased connectivity of the olfactory nucleus (ON) might indicate a network
phenotype less prone to depression, as olfactotry function is suggested to be a
marker for vulnerabilty to depression (Croy & Hummel, 2017).
4.5.3 Global network metrics
Our findings suggest an improvement of network integration by traxoprodil at
the low dose, but the opposite effect at the high dose. The indivdual ∆CPL
and ∆Elocal–values show, that the significance of results for the low dose are
mainly driven by three subjects in the low dose group (Figure 13). The PK/PD-
model fits show trends towards lower network effciency and longer paths with
increasing dose, reflecting a less efficient organization of the network (Figure
13), corresponding well with our previous findings (Gass et al., 2018). In a
translational study comparing the effects of ketamine on human and rat brain
networks we found small-worldness and global efficiency to be reduced by ke-
tamine in both species (Becker et al., 2016).
For lanicemine no significant group effect was detected for any dose. Never-
theless, small-worldness, global efficiency and clustering tended to increase with
dose. These tendencies were also supported by the PK/PD-model fits (Figure
13), although the trends were more subtle than for traxoprodil. The effect of
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lanicemine on general network structure tended to be opposite to the effect of
traxoprodil, but due to the lack of significance, this tendency cannot be claimed
with certainty.
4.5.4 Local network metrics
Similarly to the connectivity and global network results, the effects differed
between the doses of traxoprodil. For the medium dose we observed a less cen-
tral role of RS, which might indicate a downregulation of the default-moded
network, which was found to be over-activated in depressed patients (Gudayol-
Ferré, Peró-Cebollero, González-Garrido, & Guàrdia-Olmos, 2015; Posner et al.,
2015). Its loss of centrality might be an effect of traxoprodil’s antidepressant
action. Several regions involved in reward processing (amygdala and ventral
tagmental area) gained centrality, which again shows the positive effect on re-
ward circuitry assumed to underlie our connectivity results. The less localized
role of the olfactory tubercle induced by the high and low doses further supports
this interpretation. The DRN was more involved in localized processing, which
could also indicate improved reward processing as glutamatergic drive of the
DRN regulates serotonergic activity (Soiza-Reilly & Commons, 2011). For the
high dose prelimbic and cingulate cortices showed increased centrality due to
the strengthened connections to the hippocampus.
In contrast to traxoprodil, lanicemine increased centrality of the RS at all
doses. As the RS is a central region of the default mode network (DMN),
this effect is oppsite to what was expected as a result of antidepressant action.
Centrality of the inferior colliculus was significantly decreased by the low dose.
Activation of the IC induces defensive behavior and inhibition of glutamatergic
receptors in the IC has an anxiolytic effect (de Oliveira et al., 2014). Thus the
decreased centrality of IC might indicate a less anxious network phenotype.
One result overlapping between both drugs was a decrease in degree of the
globus pallidus. The globus pallidus receives signals from the reward system
processing expected reward (Hikosaka, Bromberg-Martin, Hong, & Matsumoto,
2008). Our result might signify an effect on the network mediating reward
expectation which could be part of the antidepressant effect, as depression can
be triggered by the omission or termination of a reward. (Rolls, 2016).
49
Chapter 4 Animal study on traxoprodil and lanicemine
4.5.5 Relation to clinical results
Traxoprodil has been shown to share ketamine’s antidepressant effect along
with less severe side effects (Preskorn et al., 2008). In general the effects of
traxoprodil were not as strong as those of ketamine we found in previous studies,
which might be related to the lower efficacy found in clinical studies.
The overlap of clinical effects might be reflected in our results by similar ef-
fects on network topology, which are likely to be caused by overlapping changes
in connectivity of the hippocampal and prefrontal regions. In MDD patients
increased efficiency is explained by a more random structure of the whole brain
network (Q. Gong & He, 2015; Zhang et al., 2011). Reduced characteristic path
length was found in drug-naïve first-episode MDD (Zhang et al., 2011). Lan-
icemine shows only short-lived antidepressant action in clinical trials (Sanacora
et al., 2014; Zarate et al., 2013). Our results reflect these findings by the lack
of significant effects on network topology and Hc-PFC coupling . The extent to
which the drugs improve prefrontal-hippocampal coupling correspond well to
the clinical results. Thus, improved coupling appears to be strongly associated
with the antidepressant effect.
Regarding dissociative side effects, both traxoprodil and lanicemine show
more favourable profiles than ketamine, which induces various dissociative ef-
fects in up to 50% of subjects (Vollenweider & Kometer, 2010) and even 76%
of MDD patients (Zarate et al., 2006). Such effects were rarely observed for
traxoprodil (Preskorn et al., 2008) and not reported for lanicemine (Zarate et
al., 2013). As this correspods well to the effect on intra-PFC connectivity, we
conclude that effects on the connectivity within the PFC might rather reflect
the dissociative effects of NMDA antagonists than their antidepressant effects,
although there is evidence for a correlation of both effects (Luckenbaugh et al.,
2014).
The effects overlapping between the drugs, i.e. overlapping connectivity
changes and regional network alterations, were related to improved reward pro-
cessing. As many aspects of reward processing were found to be impaired in
depression, these network improvements might contribute to the clinical results.
4.5.6 Limitations
One possible confounding effect might be drug-anesthesia interactions. Medeto-
midine sedation is preferred over other anesthetic protocols due to its small
effect on neuronal activity (Nasrallah, Tan, & Chuang, 2012). Moreover, func-
tional connectivity in medetomidine sedated rats is similar to humans (Williams
et al., 2010). In translational studies comparing the effects of ketamine on hu-
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mans and sedated rats, we found no signs of anesthetic effects despite high doses
of the drug (Becker et al., 2016; Grimm et al., 2015). Thus, the sedation we
applied appears to be sufficiently light to avoid interaction effects.
This study was designed to investigate the acute effects of NMDA antagonists.
Clinical studies of the same drugs found effects on a timescale of hours to days
which was not covered by our investigation.
4.6 Conclusion
In general traxoprodil induced greater differences in brain networks than lan-
icemine, while neither of the two reached the level of the ketamine effects.
The action on the hippocampal-prefrontal network corresponded well to the
antidepressant efficacy found in clinical studies. Thus, hippocampal-prefrontal
coupling as well as connectivity within the PFC are possible targets for further
investigation. Especially, the relationship of hippocampal-prefrontal connec-
tivity and antidepressant effects could yield further insight to the action of
NMDA receptor antagonists and their possible application in therapy of de-
pression. The effects for both drugs differed across doses, partly even opposing
trends were observed. Nevertheless there were consistent findings across doses
and drugs. Most of the effects we found for both traxoprodil and lanicemine re-
flect improvement of reward processing which might underlie the clinical effects.
Further investigation of the effects of NMDA antoginsts on the reward system
might yield more insight into the neurobiological mechanisms underlying de-
pression and antidepressant treatment. Translational studies might be helpful
to identify promising compounds early within the drug discovery process.
4.7 Supplementary material
4.7.1 Methods
ICA denoising
In order to get rid of nuisance signals in our fMRI data we applied a denoising
approach based on independent component analysis (ICA). The basic idea is to
decompose the 4D fMRI images , i.e. voxelwise timeseries , into a number of
independent components, then identifying the components representing noise
and remove them before reconstructing the images from the remaining good
components. As suggested by Hyvarienen et. al. (Hyvärinen et al., 2001),
we ran a principal component analysis (PCA) as preliminary step, in order to
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determine the optimal number of components, which we found to be between
10 and 15. Thus, we decomposed the data into 12 components. Examples of
average image timecourses and component timecourses are shown in Figure 14.
Figure 14: ICA Denoising procedure: Decomposition of fMRI signal into 12 indepen-
dent components (IC), exclusion of components if timecourses (or derivatives) corre-
late (R>0.2) with realignment parameters/CSF signal or have large spikes (marked
with red arrows).
The crucial point in this denoising procedure is the identification of com-
ponents reflecting undesired nuisance signals. Mostly researchers using ICA
methods for denoising classify components as signal or noise by visual inspection
(Kelly et al., 2010). We chose an automated procedure avoiding the subjective
nature of manual classification. The routine we implemented was inspired by
the ICA-AROMA tool (Pruim et al., 2015), however we used a simplified ap-
proach. The classification was based on the component timecourses regardless
of spectral content or spatial distribution of the components. Components were
excluded if their timecourses correlated (R>0.2) with any of the realignment
parameters or the average timecourse from the CSF or any of their derivatives.
Additionally components were considered to reflect artefactual signal if peaks
occurring in their timecourses exceeded 5 standard deviations in height. The
same criteria were applied to the temporal derivatives of the timecourses.
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Graph metrics
First we normalized the remaining connection weights by the individual max-
imum value and thresholded the connectivity matrices by preserving the
strongest edges (20th to 45th percentile, 5% increment). We chose a relatively
high minimum density of 20% to maintain a sufficient degree of connectedness of
the network. At 20% density less than 10% of nodes were disconnected from the
rest of the network. 45% was the highest density with no negatively weighted
connections included and therefore the logical choice for maximum density.
For each subject and each density threshold we calculated several graph theo-
retical properties of the individual networks using the Brain Connectivity Tool-
box (Rubinov & Sporns, 2010, 2011):
Node degree: The number of connections a node has
Betweenness centrality: The fraction of all shortest paths in the network pass-
ing through a given node
Local clustering coefficient: The fraction of possible connections among the
neighbours of a given node weighted by the connection weights
Global clustering coefficient: The average of local clustering coefficients
across all nodes
Characteristic path length: The average weighted length of shortest paths be-
tween all pairs of nodes
Small-world index: The quotient of clustering coefficient and characteristic
path length
Global efficiency: Average inverse shortest path length
Local efficiency: Efficiency of the neighbourhood of a given node
The clustering coefficients and path lengths as well as global and local ef-
ficiencies were normalized by the according quantities calculated for a null
model, a network generated by randomizing topology while preserving degree
and strength distributions (Rubinov & Sporns, 2010, 2011).
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4.7.2 Additional results
PK/PD-modelling
Emax–fits of the network metrics 30 min after injection did not principally differ
from those of the 15 min networks, which are shown in Figure 15. The similarity
between the 15 min and 30 min plots reflects the absence of significant effects
of time in the 2-way-ANOVAs of graph metrics.
Figure 15: ∆ network metrics (15 min - baseline) vs concentration of traxoprodil in
the brain. Emax model fits reveals increase in characteristic path length and decrease
in global efficiency .In the low dose group there are three subjects showing considerably
higher efficiency and lower characteristic path length.
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Discussion
5.1 Establishment of network methods in
preclinical studies
One aim of this work was to translate network methods, which are well estab-
lished in clinical studies, to the realm of preclinical research in rats. The trans-
latability of results to clinical investigations is an important issue in preclinical
research. Despite the translational potential of network methods, studies di-
rectly comparing brain networks across species are rare.
In the translational study presented in chapter 3, ketamine induced largely
congruent network reconfigurations in humans and rats. In both species ke-
tamine reduced network integration while increasing segregation. The effect of
ketamine on interregional connectivity was also comparable in humans and rats.
Prefrontal connectivity was increased in both species. With this study directly
comparing results in humans and rats, network scientific methods have been
shown to provide results which are translatable across species. With this direct
translational approach, we demonstrated that properties of brain networks can
be valuable biomarkers for translational drug research.
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In addition to the studies presented in detail in chapters 3 and 4, similar net-
work methods have been applied in another pharmacological study investigating
effects of NMDA antagonists. Gass et al. (2018) found network alterations in-
duced by ketamine and traxoprodil which were comparable to what is presented
above, which further supports the validity and reliability of network methods.
Furthermore, the usage of the network methods, which were implemented in
the course of this project, is not restricted to pharmacological studies. The
methods have been used for several studies conducted by the research group
Translational Imaging in recent years (see 2.3). We found network effects in
animal models of depression (Gass et al., 2016; Clemm von Hohenberg et al.,
2018), early life stress (Reinwald et al., 2018) and neuropathic pain (Bilbao et
al., 2018). The variety of studies on different subjects of research, in which we
found network alterations, demonstrates the methods’ versatility for all kinds
of rs-fMRI studies and shows that they have been established as part of the
resting state analysis routine.
5.2 Effects of NMDA antagonists on rat brain
networks
The network effects of three NMDA antagonists (ketamine, traxoprodil, and
lanicemine) were investigated in order to find potential relationships of func-
tional networks with the antidepressant effect of these drugs. In the study
presented in chapter 4 network effects of traxoprodil and lanicemine have been
investigated and compared to each other and to the effects of ketamine. Com-
paring the effects of antagonists differing in their mechanisms of action, might
help gaining insight into the relationship of biochemical mechanisms, network
effects, and clinical efficacy.
While ketamine greatly increased hippocampal-prefrontal coupling in an ear-
lier study (Gass et al., 2014), the increase caused by traxoprodil was weaker
and lanicemine hardly induced any significant changes. Hippocampal-prefrontal
pathways are involved in a variety of fundamental congnitive processes (e.g.
working memory and learning) and are impaired by various psychiatric disor-
ders including depression (Godsil et al., 2013; Sampath et al., 2017). Further-
more the Hc-PFC network and its response to ketamine have been found across
species (Schwarz, Gass, Sartorius, Zheng, et al., 2013; Grimm et al., 2015).
Considering the results of clinical studies, showing stronger antidepressant ac-
tion for ketamine than for traxoprodil and only short lived effect of lanicemine
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(Zarate et al., 2006; Preskorn et al., 2008; Zarate et al., 2013), our results sup-
port the hypothesis that hippocampal-prefrontal coupling is a key feature of
glutamatergic antidepressants.
Interestingly, the connectivity within the PFC was increased by ketamine
but decreased by traxoprodil. Possibly this reflects the more severe dissociative
side effects of ketamine. However it also might reflect its higher antidepressant
efficacy, as it is suspected that antidepressant and dissociative effects originate
from the same or at least overlapping neurocircuitry (Luckenbaugh et al., 2014;
Niciu et al., 2018).
Ketamine and traxoprodil evoked a reduction of network integration and
small-worldness. Lanicemine had no significant effect on global network prop-
erties but the tendencies of the insignificant results suggest improved integra-
tion contradicting the results of ketamine and traxoprodil. In MDD patients
increased network integration was found and interpreted as more randomized
network structure (Q. Gong & He, 2015; Zhang et al., 2011). Ketamine and
traxoprodil possibly act antidepressantly by counteracting this randomization.
However it has to be noted that network effects of depression are diverse due
to the heterogeneity of the disease and large variation of patient cohorts (e.g.
medication, age, stage of depression, comorbidities).
Traxoprodil and lanicemine showed overlapping effects on many functional
connections involving regions related to the reward system. Among others,
connections of the ventral striatum (nucleus accumbens and olfactory tuber-
cle), dorsal raphe nucleus as well as thalamic and hippocampal regions were
affected. Regarding graph theoretical metrics, betweenness centrality of reward
related regions like hippocampus, amygdala and thalamus were improved by
traxoprodil. All these results suggest an improvement of reward processing in-
duced by the drugs. In a very similar study, we found according effects for
ketamine and traxoprodil (Gass et al., 2018). Impaired function of the reward
system was found in patients suffering from depression (Satterthwaite et al.,
2015). Thus, our findings suggest that the antidepressant effect of NMDA an-
tagonists might be mediated by improved reward processing.
All drugs examined here, ketamine, traxoprodil, and lanicemine induced sig-
nificant network alterations. However, the effects of traxoprodil and lanicemine
were less pronounced than those of ketamine. Despite partly parallel results,
lanicemine appears to act differently from ketamine and traxoprodil, which is
possibly related to its lower efficacy in clinical studies. Traxoprodil’s effect on
brain networks were largely similar to those of ketamine. As traxoprodil, un-
like ketamine, specifically acts on the NR2B subtype of NMDA receptors, these
findings support the hypothesis that antidepressant effects of both drugs are
driven by the action on that subtype.
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5.3 Limitations
The effects of ketamine and traxoprodil on brain networks were generally con-
gruent. However there are some methodological limitations to be considered.
The network definition strategies differed between the two studies presented in
chapters 3 and 4 respectively. In the translational ketamine study we exam-
ined binarized networks at relatively low densities between 0.05 and 0.2. The
effects of traxoprodil and lanicemine were studied in weighted networks with
higher densities between 0.2 and 0.45. Nevertheless, the global network results
for ketamine presented in chapter 4 (Figure 12 which were calculated from the
same ketamine dataset for comparison, are very similar to those in the trans-
lational study. Thus the drug effects appear to be independent of binarization
and choice of network density to some extent.
Another aspect possibly confounding the comparability of results is the vari-
ance in image preprocessing between the studies. Especially the filtering of
motion artefacts differs between linear regression of motion parameters in the
ketamine rats and different ICA based methods in the human ketamine group
as well as the traxoprodil and lanicemine study. Again, the similarity of results
for ketamine and traxoprodil across studies (also in comparison to Gass et al.
(2018)) indicates their robustness regardless of the preprocessing strategy.
Finally, the studies discussed here all focussed on the acute effects of the
drugs. There is evidence however that the antidepressant effect of the drugs is
different on the timescale of hours or days.
5.4 Future work
To better understand the action of NMDA antagonists and more importantly
to evaluate their antidepressant potential, it is important to relate the network
findings more closely to depression. In order to achieve this rapprochement to
depression, functional connectivity data from a study using ketamine treatment
in a rat model of depression is already being analysed.
Recently, there is growing interest in dynamic brain connectivity in the neu-
roscience community, since the resting state was found to be less stable than
expected (Chang & Glover, 2010; Bassett et al., 2013). Figure 16 shows the
principle of dynamic network analysis using a sliding window approach. Net-
works are calculated in the same way as with static connectivity, but only over
a small time window (usually a few minutes) of the regional fMRI signals. By
sliding the window over the total length of the timecourses, a series of networks
is calculated. Thus, the dynamics of network behaviour can be analysed.
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Figure 16: Dynamic network analysis. A: A series of networks is calculated according
to the static case by sliding the time window of interest over the total length of the
timecourses. B: Dynamics of network efficiency for a single subject
Figure 16 shows data of a single traxoprodil treated subject from the study
presented in chapter 4. The variation visible in both, network matrices(A) and
network efficiency(B) show that network dynamics are a promising subject of
future research.
Making use of these methods could be especially interesting for pharmaco-
logical network studies, as they might facilitate time-resolved measurement of
acute drug effects. The acute and long term effects of NMDA antagonists are
supposed to differ. Thus, observing the effects of the drug with higher temporal
resolution might yield further insight into their mechanisms of action.
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5.5 Conclusion
Network methods provide reliable results across studies and
species
In the course of this work, network scientific methods using the formalism of
graph theory were successfully implemented. The translational validity of these
methods in pharmacological studies was shown in a study directly comparing
network effects of ketamine between humans and rats. Furthermore, network
methods were established as part of the resting state analysis routine and ap-
plied in various studies.
Congruent effects of ketamine and traxoprodil suggest
important role of NR2B subtype
The effects of traxoprodil, increased hippocampal-prefrontal coupling and re-
duced network integration, were congruent with effects of ketamine. Since trax-
oprodil specifically acts on the NR2B subtype of the receptor, these findings
support the hypothesis, that NR2B receptors are especially involved in the an-
tidepressant action of the drugs.
Contradicting effects on intra-PFC coupling possibly related
to dissociative effect
Unlike ketamine, traxoprodil and lanicemine did not increase intra-PFC con-
nectivity. This contradiction in the network effects might be related to the more
severe dissociative effects reported for ketamine.
Acute antidepressant effect possibly mediated by improved
reward processing
All three drugs induced an improvement of reward processing represented in
local network properties as well as overlapping connectivity effects. Thus the
overlapping acute but short lived antidepressant effect might be mediated by
improved reward processing.
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In recent years network methods have gained great popularity in the analy-
sis of resting state data obtained by functional magnetic resonance imaging
(fMRI). Network alterations have been found to be induced by various psychi-
atric disorders as well as drug induced states. Depression, being one of the
most prevalent psychiatric disorders, is of special interest for psychiatric re-
search. Brain networks have been found to be affected by depression in many
clinical studies examining a variety of patient cohorts (different ages, types of
depression, treatment status).
Ketamine, an N-methyl-d-aspartate (NMDA) receptor antagonist, was found
to act antidepressantly at sub anaesthetic doses. In contrast to conventional
antidepressants (e.g. selective serotonin reuptake inhibitors), ketamine acts
very quickly (within hours) and reliably even in treatment resistant patients.
However ketamine also induces dissociative effects, often perceived as aversive.
Since this discovery was made, other NMDA receptor antagonists are examined
as potential glutamatergic antidepressants sharing ketamine’s antidepressant
action but not its dissociative effects. Two candidate drugs were investigated
here: Lanicemine (AZD7665), a low trapping NMDA channel blocker, and trax-
oprodil, a non-competitive antagonist targeting the NR2B subgroup of the re-
ceptor.
One objective of this work was the translation of network methods mostly
developed for human studies to preclinical fMRI and the demonstration of their
translational potential in a study comparing effects of ketamine across species.
Network alterations were supposed to be similar in humans and rats.
As expected, we found largely congruent effects (see chapter 3). In both
species ketamine induced a more segregated network structure as well as large-
scale connectivity alterations. These results show the direct translatability of
network methods across species and therefore underline their potential for pre-
clinical neuroscientific research.
Furthermore the network effects of traxoprodil and lanicemine were investi-
gated in another fMRI study in rats (see chapter 4). Based on to the effects of
ketamine found in previous studies we expected increased connectivity in the
hippocampal-prefrontal (Hc-PFC) network as well as reduced network integra-
tion. For traxoprodil results were expected to be generally similar to those found
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for ketamine. Due to its similar mechanism of action we expected similar but
less pronounced results for lanicemine compared to ketamine. Nevertheless, de-
viating results between different NMDA antagonists might help explaining the
mechanisms underlying their effects.
Like ketamine, traxoprodil induced an increase in Hc-PFC coupling, however
its effect was less pronounced. Lanicemine hardly had any significant effect on
this subnetwork. The extent to which Hc-PFC coupling was induced by the
three drugs corresponds well to their antidepressant efficacy in clinical trials,
which suggests a central role of Hc-PFC coupling in the action of glutamatergic
antidepressants.
Regarding the effects on graph theoretical network properties, traxoprodil
and ketamine induced a reduction of network integration. Once more, the
effects induced by ketamine and traxoprodil were similar, while lanicemine had
no significant effect. This again reflects the clinical efficacy of the drugs.
All three drugs induced improvement of reward processing as reflected by
connectivity alterations and effects on local network properties in reward related
brain areas.
The differing results for Hc-PFC coupling and global network properties sug-
gest that lanicemine’s lower clincal efficacy compared to ketamine and traxo-
prodil is related to these network phenotypes.
Since traxoprodil exclusively acts on the NR2B subtype of the NMDA recep-
tor, the parallel results suggest a central role of this subtype for the action of
glutamatergic antidepressants.
Acute and long-term effects of NMDA antagonists are supposed to differ
considerably. Thus, the dynamics of network effects deserves further research.
Data comparing acute and long-term effects of ketamine on functional networks
are already being analysed. Future investigations of network dynamics could
benefit from recent advances in dynamic connectivity methodology.
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